
|Articles|May 25, 2022
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
Advertisement
Promontory Therapeutics Inc. announced the appointment of Johan Baeck, MD, as Executive Vice President and Chief Medical Officer. Dr. Baeck joins Promontory Therapeutics from Jounce Therapeutics where he served as Senior Vice President, Clinical Development and Medical Affairs.
Read more about the appointment
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Emerging Pharma Leaders
2
Pharmaceutical Executive Daily: 2026 Emerging Pharma Leaders Award Winners Announced
3
Two Decades of Technology Transformation in Pharma
4
Pharmaceutical Cold-Chain Logistics: Protecting Integrity from End to End (Aug 2026)
5




